Indrani Franchini

Insider Reports History

Entity
Individual
Location
C/O Alexion Pharmaceuticals, Inc, 100 College Street, New Haven, Connecticut
Signature
/s/ Mojirade James, attorney-in-fact for Indrani Franchini pursuant to power of attorney filed herewith.
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Indrani Franchini:

Stock Role Class Num Shares Value Price $ Report Date Ownership
ALNYLAM PHARMACEUTICALS, INC. EVP, CLO & Secretary Common Stock 4.13K $653K $158.09 Feb 28, 2024 Direct
ALNYLAM PHARMACEUTICALS, INC. EVP, CLO & Secretary Restricted Stock Units 1.75K $261K $149.03 Feb 27, 2024 Direct
AVANOS MEDICAL, INC. Director Common Stock 4.82K $92K $19.09 Jul 1, 2024 Direct
ALEXION PHARMACEUTICALS, INC. EVP, Chief Compliance Officer Common Stock, par value $.0001 per share 0 $177.00 Jul 21, 2021 Direct
ALEXION PHARMACEUTICALS, INC. EVP, Chief Compliance Officer Option to Purchase Common Stock 0 $155.01 Jul 21, 2021 Direct

Insider Reports Filed by Indrani Franchini

Symbol Company Period Transactions Value $ Form Type Date Filed Role
AVNS AVANOS MEDICAL, INC. Jul 1, 2024 0 $0 3/A Jul 3, 2024 Director
ALNY ALNYLAM PHARMACEUTICALS, INC. Feb 27, 2024 7 -$51.1K 4 Feb 29, 2024 EVP, CLO & Secretary
ALNY ALNYLAM PHARMACEUTICALS, INC. Feb 1, 2024 5 -$272K 4 Feb 5, 2024 EVP, CLO & Secretary
ALNY ALNYLAM PHARMACEUTICALS, INC. Apr 6, 2023 1 -$735K 4 Apr 10, 2023 EVP, CLO & Secretary
ALNY ALNYLAM PHARMACEUTICALS, INC. Feb 27, 2023 2 $0 4 Mar 1, 2023 EVP, CLO & Secretary
ALNY ALNYLAM PHARMACEUTICALS, INC. Feb 1, 2023 6 -$379K 4 Feb 3, 2023 EVP, CLO & Secretary
ALNY ALNYLAM PHARMACEUTICALS, INC. Feb 1, 2022 2 $0 4 Feb 9, 2022 EVP, CLO & Secretary
ALNY ALNYLAM PHARMACEUTICALS, INC. Jan 31, 2022 0 $0 3 Feb 9, 2022 EVP, CLO & Secretary
ALXN ALEXION PHARMACEUTICALS, INC. Jul 21, 2021 2 -$2.52M 4 Jul 23, 2021 EVP, Chief Compliance Officer
ALXN ALEXION PHARMACEUTICALS, INC. Jul 14, 2021 2 $0 4 Jul 16, 2021 EVP, Chief Compliance Officer
ALXN ALEXION PHARMACEUTICALS, INC. Jun 8, 2021 1 -$164K 4 Jun 9, 2021 EVP, Chief Compliance Officer